There are 35 resources available
Optimal treatment sequencing options in urothelial cancer
Presenter: Srikala Sridhar
Session: Merck - Raising the bar: Advancing bladder cancer treatment
Resources:
Webcast
Exploring new actionable targets in advanced gastric and GEJ cancers
Presenter: Sun Young Rha
Session: Amgen - The future of advanced GI cancer therapies: New approaches on the horizon?
Resources:
Webcast
Translating scientific evidence into tumour agnostic drug approvals
Presenter: Jee Hyun Kim
Session: F. Hoffmann-La Roche Ltd. - Shaping the future of personalised healthcare for cancer patients
Resources:
Webcast
Audience Q&A Conclusion
Presenter: Ravindran Kanesvaran
Session: Merck - Raising the bar: Advancing bladder cancer treatment
Resources:
Webcast
Panel discussion and Q&A
Presenter: All Speakers
Session: Amgen - The future of advanced GI cancer therapies: New approaches on the horizon?
Resources:
Webcast
Shaping public healthcare systems to accelerate treatment access
Presenter: Nick Pavlakis
Session: F. Hoffmann-La Roche Ltd. - Shaping the future of personalised healthcare for cancer patients
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: F. Hoffmann-La Roche Ltd. - Shaping the future of personalised healthcare for cancer patients
Resources:
Webcast
Call to action
Presenter: Jee Hyun Kim
Session: F. Hoffmann-La Roche Ltd. - Shaping the future of personalised healthcare for cancer patients
Resources:
Webcast
Welcome and opening remarks
Presenter: Han Chong Toh
Session: F. Hoffmann-La Roche Ltd. - HCC illuminated: Exploring future frontiers with systemic immunotherapies
Resources:
Webcast
Plenary presentation: Expanding role of systemic immunotherapy in the management of HCC
Presenter: Ann-Lii Cheng
Session: F. Hoffmann-La Roche Ltd. - HCC illuminated: Exploring future frontiers with systemic immunotherapies
Resources:
Webcast